175 related articles for article (PubMed ID: 38133505)
21. An optimized gene transfection system in WERI-Rb1 cells.
Liu Y; Fan Z; Li K; Deng F; Xiong Y; Liang M; Ge J
Int J Mol Med; 2017 Sep; 40(3):801-813. PubMed ID: 28713896
[TBL] [Abstract][Full Text] [Related]
22.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
23. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
24. Investigation of new candidate genes in retinoblastoma using the TruSight One "clinical exome" gene panel.
Akdeniz D; Tuncer SB; Kebudi R; Celik B; Kuru G; Kilic S; Sukruoglu Erdogan O; Avsar M; Buyukkapu Bay S; Tuncer S; Yazici H
Mol Genet Genomic Med; 2019 Aug; 7(8):e785. PubMed ID: 31207142
[TBL] [Abstract][Full Text] [Related]
25. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
[TBL] [Abstract][Full Text] [Related]
26. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
28.
Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
[No Abstract] [Full Text] [Related]
29. Bilateral retinoblastoma with one eye manifesting only posterior chamber infiltration and no retinal involvement.
Ossandon D; Kastner A; Zanolli M; Solanes F; Pérez V; Repetto G; Benavides F; Shields CL
J AAPOS; 2016 Dec; 20(6):548-550.e1. PubMed ID: 27815188
[TBL] [Abstract][Full Text] [Related]
30. Low-grade glioma: A rare second tumor in retinoblastoma survivors.
Dalvi N; Kleinerman RA; Epelman S; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2021 Feb; 68(2):e28770. PubMed ID: 33063942
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
Singh J; Mishra A; Pandian AJ; Mallipatna AC; Khetan V; Sripriya S; Kapoor S; Agarwal S; Sankaran S; Katragadda S; Veeramachaneni V; Hariharan R; Subramanian K; Mannan AU
Mol Vis; 2016; 22():1036-47. PubMed ID: 27582626
[TBL] [Abstract][Full Text] [Related]
32. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma.
Fukushima H; Suzuki R; Hiraoka T; Suzuki S; Noguchi E; Takada H
Jpn J Clin Oncol; 2023 Aug; 53(9):863-865. PubMed ID: 37345682
[TBL] [Abstract][Full Text] [Related]
33. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma.
Kakkassery V; Gemoll T; Kraemer MM; Sauer T; Tura A; Ranjbar M; Grisanti S; Joachim SC; Mergler S; Reinhard J
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409416
[TBL] [Abstract][Full Text] [Related]
34. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
35. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
36. Retinoblastoma and tumor-suppressor gene therapy.
Xu HJ
Ophthalmol Clin North Am; 2003 Dec; 16(4):621-9. PubMed ID: 14741002
[TBL] [Abstract][Full Text] [Related]
37. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).
Kugalingam N; De Silva D; Abeysekera H; Nanayakkara S; Tirimanne S; Ranaweera D; Suravajhala P; Chandrasekharan V
BMC Med Genomics; 2023 Nov; 16(1):279. PubMed ID: 37932687
[TBL] [Abstract][Full Text] [Related]
38. Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site.
Ravishankar H; Mangani AS; Shankar MB; Joshi M; Devasena T; Parameswaran S; Subramaniam K
Histochem Cell Biol; 2020 Feb; 153(2):101-109. PubMed ID: 31781967
[TBL] [Abstract][Full Text] [Related]
39. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
40. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
Lee C; Kim JK
J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
